Relief Therapeutics Holding AG
MindMaze Therapeutics Holding SA develops and operates the MindMaze platform that integrates neuroscience and digital therapeutics to address some of the most pressing challenges in neurology. MindMaze Therapeutics Holding SA was formerly known as NeuroX Group SA. The company was incorporated in 2025 and is based in Lausanne, Switzerland.
Relief Therapeutics Holding AG (RLFTY) - Total Liabilities
Latest total liabilities as of June 2025: $15.35 Million USD
Based on the latest financial reports, Relief Therapeutics Holding AG (RLFTY) has total liabilities worth $15.35 Million USD as of June 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Relief Therapeutics Holding AG - Total Liabilities Trend (2017–2024)
This chart illustrates how Relief Therapeutics Holding AG's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Relief Therapeutics Holding AG Competitors by Total Liabilities
The table below lists competitors of Relief Therapeutics Holding AG ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
YOUNGHWA TECH Co. Ltd
KQ:265560
|
Korea | ₩27.53 Billion |
|
MotorK Ltd
AS:MTRK
|
Netherlands | €42.11 Million |
|
Canagold Resources Ltd
OTCQB:CRCUF
|
USA | $3.38 Million |
|
Whitestone Group
BR:ROCK
|
Belgium | €410.99K |
|
HMA AGRO INDUSTRIES ORD (BSE)
NSE:HMAAGRO
|
India | ₹8.82 Billion |
|
Spyrosoft S.A.
WAR:SPR
|
Poland | zł89.73 Million |
|
West Vault Mining Inc
OTCQX:WVMDF
|
USA | $14.01 Million |
|
I&C Technology Co. Ltd
KQ:052860
|
Korea | ₩16.71 Billion |
Liability Composition Analysis (2017–2024)
This chart breaks down Relief Therapeutics Holding AG's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 4.05 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.47 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.32 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Relief Therapeutics Holding AG's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Relief Therapeutics Holding AG (2017–2024)
The table below shows the annual total liabilities of Relief Therapeutics Holding AG from 2017 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $16.56 Million | -31.46% |
| 2023-12-31 | $24.16 Million | -44.30% |
| 2022-12-31 | $43.38 Million | -38.10% |
| 2021-12-31 | $70.09 Million | +537.05% |
| 2020-12-31 | $11.00 Million | +97.70% |
| 2019-12-31 | $5.57 Million | -61.06% |
| 2018-12-31 | $14.29 Million | +42.56% |
| 2017-12-31 | $10.03 Million | -- |